February 27, 2015
by MMJ Publisher
Source: PharmaCan Capital Corp. Press Release
TORONTO, ONTARIO–(Marketwired – Feb. 27, 2015) -
PharmaCan Capital Corp. (TSX VENTURE:MJN) (“PharmaCan”) is pleased to announce that The Whistler Medical Marijuana Company (“WMMC”) has received notice from Health Canada confirming the renewal of its Marihuana for Medical Purposes Regulation (“MMPR”) license. PharmaCan has a 21.4% ownership interest in WMMC.
“This is another in a series of incredible milestones for WMMC. Following on the heels of receiving approval from Health Canada to begin producing in three new production rooms in December 2014, this renewal positions WMMC for an incredibly bright future as an integral supplier of medicine under Canada’s MMPR program.” said Paul Rosen, PharmaCan’s President and CEO. Mr. Rosen added that “The unique Whistler brand is already recognized globally, and we are confident that WMMC will become one of the most recognized and respected companies in our emerging industry. 2015 is shaping up to be an incredible year of growth and opportunity for the Whistler Medical Marijuana Company.”
Mr. Rosen continued “Today is a hallmark day for PharmaCan, and its investee companies. With license renewals this week at both Whistler Medical Marijuana and In the Zone, we feel more confident than ever that PharmaCan is building towards creating the most durable income stream generated from the sale of medical marihuana in Canada.”
About PharmaCan Capital Corp.
PharmaCan is a company in the business of investing in companies either licensed, or actively seeking a license, to produce medical marihuana pursuant to Canada’s MMPR. PharmaCan has a diversified portfolio of investments including investments in 5 of the 25 companies licensed by Heath Canada to produce medical marihuana.
About Whistler Medical Marijuana
WMMC, based in Whistler, British Columbia, received its original MMPR license in February 2014. The Fraser Valley Organic Producers Association certifies WMMC as organic. WMMC currently operates out of a 12,500 square foot facility that it owns. It has negotiated an option to purchase the remainder of the units in its building, which when exercised upon, would increase the total facility size to 33,000 square feet. PharmaCan has a 21.4% ownership interest in WMMC.
Recent CRON News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/30/2024 09:03:08 PM
- Lord Jones® Live Resin Vapes and Ice Water Hash Pre-Rolls Now Available Across Canada • GlobeNewswire Inc. • 08/28/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 09:03:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 09:02:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 09:01:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:32:54 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:31:44 AM
- Cronos Group Reports 2024 Second Quarter Results • GlobeNewswire Inc. • 08/08/2024 11:30:00 AM
- U.S. Index Futures Drop, Signaling Ongoing Market Volatility; Oil Prices Stall • IH Market News • 08/08/2024 09:55:44 AM
- Cronos Group Inc. to Hold 2024 Second Quarter Earnings Conference Call on August 8, 2024 • GlobeNewswire Inc. • 07/25/2024 08:15:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/22/2024 08:32:05 PM
- Cronos Group Inc. Announces Results of Reconvened 2024 Annual Meeting of Shareholders • GlobeNewswire Inc. • 07/22/2024 08:15:00 PM
- Cronos Group Inc. to Reconvene Virtual 2024 Annual Meeting of Shareholders • GlobeNewswire Inc. • 07/05/2024 08:30:00 PM
- Cronos Brand Spinach® Celebrates Summer with New Launches • GlobeNewswire Inc. • 06/27/2024 11:30:00 AM
- Cronos Group Inc. Announces Results of 2024 Annual Meeting of Shareholders • GlobeNewswire Inc. • 06/21/2024 08:30:00 PM
- Cronos Group Announces Expansion of GrowCo to Fuel Global Growth • GlobeNewswire Inc. • 06/20/2024 12:12:02 PM
- Cronos Group Inc. to Speak at Bernstein's 40th Annual Strategic Decisions Conference • GlobeNewswire Inc. • 05/29/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/28/2024 09:32:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/28/2024 09:32:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 09:02:27 PM
- Cronos Terminates Sale-Leaseback of Peace Naturals Campus • GlobeNewswire Inc. • 05/28/2024 08:45:00 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/15/2024 09:02:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 09:09:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 09:06:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 09:05:10 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM